Literature DB >> 34108096

MAFLD vs NAFLD: Where are we?

Alessandro Mantovani1.   

Abstract

Entities:  

Keywords:  MAFLD; Metabolic associated fatty liver disease; NAFLD; NASH; Nonalcoholic fatty liver disease; Nonalcoholic steatohepatitis

Mesh：

Year:  2021        PMID： 34108096     DOI： 10.1016/j.dld.2021.05.014

Source DB:  PubMed          Journal:  Dig Liver Dis        ISSN： 1590-8658            Impact factor:   4.088


× No keyword cloud information.
  3 in total

Review 1.  MAFLD and CKD: An Updated Narrative Review.

Authors:  Alessandro Mantovani; Rosa Lombardi; Filippo Cattazzo; Chiara Zusi; Davide Cappelli; Andrea Dalbeni
Journal:  Int J Mol Sci       Date:  2022-06-23       Impact factor: 6.208

Review 2.  Non-Alcoholic Fatty Liver Disease and Risk of Macro- and Microvascular Complications in Patients with Type 2 Diabetes.

Authors:  Alessandro Mantovani; Andrea Dalbeni; Giorgia Beatrice; Davide Cappelli; Fernando Gomez-Peralta
Journal:  J Clin Med       Date:  2022-02-12       Impact factor: 4.241

Review 3.  Immunotherapy for nonalcoholic fatty liver disease-related hepatocellular carcinoma: Lights and shadows.

Authors:  Federico Costante; Carlo Airola; Francesco Santopaolo; Antonio Gasbarrini; Maurizio Pompili; Francesca Romana Ponziani
Journal:  World J Gastrointest Oncol       Date:  2022-09-15
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.